about
The challenges of diagnosing primary ciliary dyskinesiaDiagnosis, monitoring, and treatment of primary ciliary dyskinesia: PCD foundation consensus recommendations based on state of the art reviewNasal nitric oxide in manElectronic Noses for Well-Being: Breath Analysis and Energy ExpenditureQuantitative analysis of ciliary beating in primary ciliary dyskinesia: a pilot studyExhaled nitric oxide in diagnosis and management of respiratory diseases.Cystic fibrosis lung disease: the role of nitric oxide.Gas analysis.Interferon γ stimulates accumulation of gas phase nitric oxide in differentiated cultures of normal and cystic fibrosis airway epithelial cellsThe role of inhaled corticosteroids in the management of cystic fibrosis.Exhaled markers of pulmonary disease.ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005.Deciphering miRNA transcription factor feed-forward loops to identify drug repurposing candidates for cystic fibrosis.Biomarkers of some pulmonary diseases in exhaled breath."CF asthma": what is it and what do we do about it?Reduced nasal nitric oxide production in cystic fibrosis patients with elevated systemic inflammation markers.Chronic pancreatitis and cystic fibrosis.Nitrite levels in breath condensate of patients with cystic fibrosis is elevated in contrast to exhaled nitric oxide.Exhalation flow and pressure-controlled reservoir collection of exhaled nitric oxide for remote and delayed analysis.Increased carbon monoxide in exhaled air of patients with cystic fibrosis.An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications.Exhaled breath condensate pH and exhaled nitric oxide in allergic asthma and in cystic fibrosis.Potential of anti-inflammatory treatment for cystic fibrosis lung disease.Clinical value of measurement of pulmonary radioaerosol mucociliary clearance in the work up of primary ciliary dyskinesia.Primary ciliary dyskinesia: current state of the art.Inducible NO synthase expression is low in airway epithelium from young children with cystic fibrosisVentilatory pattern and energy expenditure are altered in cystic fibrosis mice.Assessment of airway inflammation with exhaled NO measurement.Primary ciliary dyskinesia: improving the diagnostic approach.Sputum biomarkers of inflammation in cystic fibrosis lung diseaseAntibiotic and anti-inflammatory therapies for cystic fibrosis.The use of exhaled nitric oxide in the management of asthma.Inducible nitric oxide synthase expression is reduced in cystic fibrosis murine and human airway epithelial cells.Nasal nitric oxide and sinonasal disease: a systematic review of published evidence.Nitric oxide: a promising methodological approach in airway diseases.Primary ciliary dyskinesia: recent advances in epidemiology, diagnosis, management and relationship with the expanding spectrum of ciliopathy.Clinical application of nasal nitric oxide measurement in pediatric airway diseases.Inflammation and its genesis in cystic fibrosis.Application of nitric oxide measurements in clinical conditions beyond asthma.Erythrocytes of humans with cystic fibrosis fail to stimulate nitric oxide synthesis in isolated rabbit lungs.
P2860
Q27027926-6A761714-15B2-43A0-A04F-59E00D7CC019Q28082500-38238D05-BD31-409B-8C3A-01AAEB32F208Q28764234-C28D590A-0B13-4088-B859-D65D3445AD47Q28828188-A3E197AC-AB61-4EA6-952D-F521FCECCDCBQ30533929-963E68F4-5F82-4D3C-A825-75363423A9CBQ33568617-C788B40A-1286-48C4-9326-CE959036B168Q33787847-ABDF2A6B-2639-48CB-B855-DD8E5EC78885Q33996597-A23C694C-1127-4744-9166-AF5FE4AD7961Q34121217-3E454FA7-4594-414F-9F19-F658CBE8D018Q34131911-6930D595-5387-4BF5-889D-F8AEEEA9A54FQ34279117-EACA828A-1693-41E4-9E72-3E9EFCB52A10Q34409752-BA1E7CF4-2155-4D6B-A5AA-F9B60AA95C1BQ34636525-FDF73CBD-1A4F-4AB1-969A-9F812410BE40Q34724535-DB083169-1CC1-49DC-9A1C-6B6BC4795CFAQ34768021-9145B26C-B26F-4315-BFE5-7D6396F4EBD6Q35043722-C94C71BD-1041-45C4-9FDF-6310307976C1Q35090222-D83E145C-2D0A-4D4D-A792-0CBA9B59F7B1Q35532597-8B8AC2D2-D21C-4C87-B879-2CAABC75DAF7Q35532721-E694B6BA-C55E-4F68-B198-1A0F4B1181ADQ35532841-B80E036D-71C3-4A93-9BE7-119389F7CFE7Q35534747-0C3AA4CE-73B7-45EF-BC89-E7E66AFC12AFQ35537039-D8E5548F-7914-48F0-B591-6AE5D567C9B4Q35557381-C9B4CD84-9DA9-4BE4-B724-253316270EF9Q35855793-1597B2C9-A50B-4B82-B811-0871512D46D6Q36121455-3771D93C-00FF-4932-8819-6A224DEE402AQ36203136-80A3D9C5-067E-45C5-8BC0-48503F7CE4BBQ36750909-11343606-548D-48EC-B196-BD26F9575CD9Q36765980-1F830611-058D-49A2-BB99-855A1D53D581Q36880306-54EA29C7-21BA-4C3C-923A-418B0371EA96Q36891552-F611CD5B-8DF9-4EF8-834A-1DAEBC0EFB36Q37201467-A8978443-7790-452C-95C8-967B4621CA65Q37261439-D561EA5F-A170-4888-85EF-CA4CA6072DF1Q37387553-B07DD21E-3EE6-4C4C-9941-D37DFB4A4C22Q37884009-260591F5-9AAE-4D5B-B794-B160B8CBE8D7Q37914641-0F3CC885-42B3-45B4-8815-898E224ADF29Q38066984-99445033-A8BF-4FF7-8CA6-856AF7E9E7F8Q38243301-78F555AB-5C18-4480-88BC-9EFFB71386CFQ38579962-42F3B31E-C446-49C7-BCDC-CBB4FC01AB36Q38670757-3D52760F-4449-4509-B48D-AAB9A5E108A2Q40481982-0BB78213-9871-485F-8C7D-C5D13898CEB3
P2860
description
1996 nî lūn-bûn
@nan
1996 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Reduced upper airway nitric oxide in cystic fibrosis.
@ast
Reduced upper airway nitric oxide in cystic fibrosis.
@en
Reduced upper airway nitric oxide in cystic fibrosis.
@nl
type
label
Reduced upper airway nitric oxide in cystic fibrosis.
@ast
Reduced upper airway nitric oxide in cystic fibrosis.
@en
Reduced upper airway nitric oxide in cystic fibrosis.
@nl
prefLabel
Reduced upper airway nitric oxide in cystic fibrosis.
@ast
Reduced upper airway nitric oxide in cystic fibrosis.
@en
Reduced upper airway nitric oxide in cystic fibrosis.
@nl
P2093
P2860
P356
P1476
Reduced upper airway nitric oxide in cystic fibrosis.
@en
P2093
I M Balfour-Lynn
R Dinwiddie
P2860
P304
P356
10.1136/ADC.75.4.319
P407
P577
1996-10-01T00:00:00Z